|
Market Closed -
Other stock markets
|
After hours 21:45:08 | |||
| 121.57 USD | +0.13% |
|
121.97 | +0.33% |
Chart calendar Merck & Co., Inc.
Upcoming events on Merck & Co., Inc.
| 15/03/2026 | Add to your calendar Google Apple ICS format | |
| 30/04/2026 | Q1 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 30/04/2026 | Q1 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 03/08/2026 | Q2 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 04/08/2026 | Q2 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 29/10/2026 | Q3 2026 Earnings Release | Add to your calendar Google Apple ICS format |
| 29/10/2026 | Q3 2026 Earnings Call | Add to your calendar Google Apple ICS format |
| 03/02/2027 | Q4 2026 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 28/04/2027 | Q1 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 02/08/2027 | Q2 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
| 03/11/2027 | Q3 2027 Earnings Release (Projected) | Add to your calendar Google Apple ICS format |
Past events on Merck & Co., Inc.
| 03/02/2026 | Q4 2025 Earnings Call |
| 03/02/2026 | Q4 2025 Earnings Release |
| 13/01/2026 | J.P. Morgan Healthcare Conference |
| 14/12/2025 | |
| 03/12/2025 | Citi Global Healthcare Conference |
| 03/12/2025 | Clinical Trials on Alzheimer Disease Conference - Abstract Number P249 |
| 03/12/2025 | Clinical Trials on Alzheimer Disease Conference - Abstract Number P112 |
| 02/12/2025 | Evercore Healthcare Conference |
| 01/12/2025 | Clinical Trials on Alzheimer Disease Conference - Abstract Number P112 |
| 20/11/2025 | Jefferies Global Healthcare Conference |
| 17/11/2025 | Acquisition of Cidara Therapeutics, Inc. by Merck & Co., Inc. Call |
| 10/11/2025 | American Heart Association Meeting - Abstract Number: 4341629 |
| 09/11/2025 | American Heart Association Meeting |
| 09/11/2025 | American Heart Association Meeting - Abstract Number: 4391641 |
| 09/11/2025 | American Heart Association Meeting - Abstract Number: 4359798 |
| 08/11/2025 | American Heart Association Meeting - Abstract Number: 4391578 |
| 08/11/2025 | American Heart Association Meeting - Abstract Number: 4365782 |
| 08/11/2025 | American Heart Association Meeting - Abstract Number: 4387511 |
| 30/10/2025 | Q3 2025 Earnings Call |
| 30/10/2025 | Q3 2025 Earnings Release |
Past dividends on Merck & Co., Inc.
| 14/12/2025 | Quarterly 0.85 USD |
| 14/09/2025 | Quarterly 0.81 USD |
| 15/06/2025 | Quarterly 0.81 USD |
| 16/03/2025 | Quarterly 0.81 USD |
| 15/12/2024 | Quarterly 0.81 USD |
| 15/09/2024 | Quarterly 0.77 USD |
| 16/06/2024 | Quarterly 0.77 USD |
| 13/03/2024 | Quarterly 0.77 USD |
| 13/12/2023 | Quarterly 0.77 USD |
| 13/09/2023 | Quarterly 0.73 USD |
| 13/06/2023 | Quarterly 0.73 USD |
| 13/03/2023 | Quarterly 0.73 USD |
| 13/12/2022 | Quarterly 0.73 USD |
| 13/09/2022 | Quarterly 0.69 USD |
| 13/06/2022 | Quarterly 0.69 USD |
| 13/03/2022 | Quarterly 0.69 USD |
| 13/12/2021 | Quarterly 0.69 USD |
| 13/09/2021 | Quarterly 0.65 USD |
| 13/06/2021 | Quarterly 0.65 USD |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 59 283 59 144 0.24% | 60 115 59 938 0.3% | 64 168 63 997 0.27% | 65 011 64 779 0.36% | 66 708 | 70 445 |
|
EBITDA Million USD | Released Forecast Spread | 26 431 24 588 7.5% | 10 083 9 362 7.71% | 27 897 26 650 4.68% | 0,00 29 685 - | 21 376 | 32 578 |
|
EBIT Million USD | Released Forecast Spread | 22 522 22 363 0.71% | 6 211 6 066 2.4% | 23 398 23 593 -0.83% | 26 779 26 730 0.18% | 18 150 | 29 816 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 16 444 17 389 -5.44% | 1 889 2 857 -33.89% | 19 936 21 364 -6.68% | 21 067 22 876 -7.91% | 13 960 | 26 343 |
|
Net income Million USD | Released Forecast Spread | 14 519 14 827 -2.07% | 365 1 682 -78.3% | 17 117 17 500 -2.19% | 18 254 19 815 -7.88% | 10 423 | 21 504 |
|
EPS USD | Released Forecast Spread | 5,71 5,87 -2.73% | 0,14 0,56 -75.16% | 6,74 7,01 -3.82% | 7,28 7,74 -5.99% | 4,36 | 8,79 |
| Announcement Date | 02/02/23 | 01/02/24 | 04/02/25 | 03/02/26 |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 15 775 15 204 3.75% | 16 112 15 844 1.69% | 16 657 16 514 0.87% | 15 624 15 507 0.76% | 15 529 15 331 1.29% | 15 806 15 873 -0.42% | 17 276 16 978 1.76% | 16 400 16 206 1.2% | 15 909 | 16 407 | 17 596 | 16 924 | 16 985 | 17 730 | 19 160 |
|
EBITDA Million USD | Released Forecast Spread | 7 367 6 562 12.27% | 7 177 7 367 -2.57% | 5 466 5 999 -8.89% | 6 422 7 737 -16.99% | 7 722 6 882 12.2% | 7 484 7 160 4.52% | 8 710 8 313 4.77% | 7 843 | -1 688 | 7 402 | 8 253 | 7 072 | |||
|
EBIT Million USD | Released Forecast Spread | 6 383 5 808 9.91% | 6 659 6 519 2.14% | 4 913 5 046 -2.63% | 5 225 5 140 1.66% | 6 623 6 533 1.38% | 6 365 6 206 2.56% | 7 556 7 139 5.84% | 6 236 6 134 1.66% | -2 519 | 6 573 | 7 571 | 6 542 | |||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 5 670 5 267 7.66% | 6 006 6 023 -0.29% | 4 090 4 535 -9.82% | 4 170 4 641 -10.15% | 5 903 5 880 0.4% | 4 999 5 672 -11.86% | 6 745 6 465 4.32% | 3 420 4 751 -28.02% | -3 581 | 5 430 | 6 551 | 5 614 | |||
|
Net income Million USD | Released Forecast Spread | 4 762 4 414 7.88% | 5 455 4 942 10.38% | 3 157 3 419 -7.66% | 3 743 3 700 1.16% | 5 079 4 983 1.93% | 4 427 4 651 -4.81% | 5 785 5 155 12.22% | 2 963 4 341 -31.74% | -3 740 | 4 423 | 5 252 | 4 628 | |||
|
EPS USD | Released Forecast Spread | 1,87 1,79 4.45% | 2,14 1,93 10.86% | 1,24 1,43 -13.39% | 1,48 1,49 -0.58% | 2,01 1,93 3.97% | 1,76 1,84 -4.45% | 2,32 2,06 12.85% | 1,19 1,68 -29.16% | -1,51 | 1,74 | 2,11 | 1,86 | |||
| Announcement Date | 25/04/24 | 30/07/24 | 31/10/24 | 04/02/25 | 24/04/25 | 29/07/25 | 30/10/25 | 03/02/26 | - | - | - | - | - | - | - |
| 17/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 17/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 18/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 19/02/2026 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple ICS format | |
| 20/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format | |
| 22/02/2026 | Q4 2025 Earnings Release | Add to your calendar Google Apple ICS format |
Past sector events for Merck & Co., Inc.
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 13/02/2026 | Q3 2026 Earnings Release | |
| 12/02/2026 | Q3 2025 Earnings Release | |
| 12/02/2026 | Q3 2025 Earnings Release | |
| 12/02/2026 | Q4 2025 Earnings Release | |
| 12/02/2026 | Q4 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- MRK Stock
- Calendar Merck & Co., Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















